• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

LIST commercially launches magSIMS – an award-winning nano-imaging instrument and signs licensing agreement with German manufacturer Raith

Bioengineer by Bioengineer
February 22, 2024
in Biology
Reading Time: 3 mins read
0
LIST commercially launches magSIMS - an award-winning nano-imaging instrument
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Luxembourg Institute of Science and Technology (LIST) announced the commercial launch of magSIMS (a Magnetic Sector Secondary Ion Mass Spectrometry system), an award-winning nano-imaging instrument, over an event, which took place on 22 February 2024 at the institute’s Belvaux campus.

LIST commercially launches magSIMS - an award-winning nano-imaging instrument

Credit: LIST

The Luxembourg Institute of Science and Technology (LIST) announced the commercial launch of magSIMS (a Magnetic Sector Secondary Ion Mass Spectrometry system), an award-winning nano-imaging instrument, over an event, which took place on 22 February 2024 at the institute’s Belvaux campus.

The occasion also marked the opening of a joint lab and the signing of a licensing contract between LIST and Raith, a prominent German manufacturer specializing in precision technology for nanofabrication, to undertake the commercialization of magSIMS.

The magSIMS is a breakthrough instrument, developed by LIST researchers, which has the ability to not only view objects in the minutest details, but also to produce chemical composition information simultaneously.

Discovering magSIMS and its various applications across multiple disciplines

Understanding the structure and chemical composition at the nanometre scale is crucial across various fields, including batteries, electronics, biology, or functional materials. This level of analysis allows for detailed examination, which for instance is required when designing new electronic devices, developing new photovoltaic materials or studying sub-cellular structures in biology.

In materials science, the magSIMS can be widely used for nano-characterization. It enables the analysis of complex 3D architectures. In photovoltaics, it helps in understanding the composition of thin films crucial for the performance and longevity of solar cells. In life sciences, it allows high-resolution chemical analysis of biological samples. And beyond materials and life sciences, magSIMS finds applications in soil science, geology, and even cultural heritage analysis.

A success story made-in-Luxembourg more than a decade in the making

The history of the technology behind magSIMS goes back a decade. “Our initial exploration focused on the feasibility of obtaining chemical information with highest sensitivity at the nano level,” says Dr Tom Wirtz, Head of Unit, Scientific Instrumentation and Process Technology at LIST. “This led us to consider ion and electron microscopy combined with mass spectrometry as a key aspect.”

In conventional electron microscopy, one can observe minuscule entities at the nano level using specialized instruments. “The challenge then was to introduce an additional dimension to this capability, which involves incorporating chemical information,” he added. The objective was not only to visualize the appearance of a sample but also to discern its composition.

This led to the development of a mass spectrometer: a technology that allows scientists to identify specific elements based on their distinct masses. The resulting nanoimaging instrument became the first microscope able to view samples in tiny details while simultaneously determining their chemical composition. The research and the technology won national and international accolades.

From lab to the market: partnership between LIST and Raith

Through various collaborations over the years, LIST’s technology has been adopted by multiple companies, leading to the installation of the instrument on numerous microscopes worldwide. However, large scale manufacturing was still limited. “While interest from the industry was evident, the production of the instrument remained with us at LIST as the demand from individual companies wasn’t large enough,” says Wirtz.

Now, however, the signing of the licensing and partnership agreement with Raith, a prominent German manufacturer specializing in precision technology for nanofabrication, has opened up the potential for the instrument to be manufactured by the company, thereby expanding its accessibility and adoption on a broader scale.

“Raith has actively collaborated with LIST over the past two years to identify and define advancements in the field of nano-analytics that are mutually beneficial,” says Wirtz. “Today, they intend to form a global partnership focusing not only on the establishment of a joint laboratory and common research and development projects, but also on manufacturing the instrument as a product for broader distribution and on providing worldwide maintenance of these instrument after they are installed.”

Talking about the instrument and the partnership with Raith, Dr Damien Lenoble, Director of the materials department at LIST, said: “The partnership and subsequent commercialization of magSIMS represent significant achievements for LIST and Luxembourg, as the technology will be now deployed worldwide thanks to our trusted partner Raith. This perfectly illustrates LIST’s core mission of leveraging early-stage research to develop unique capabilities and enhance the maturity of proprietary technologies over time. The impending changes in technologies, particularly those driving transitions in sectors such as energy, consumer electronics and mobility, make magSIMS particularly attractive as a versatile instrumentation tool. We are especially pleased to have consistently supported this research-based innovation until it reached market readiness for widespread adoption.”



Share12Tweet8Share2ShareShareShare2

Related Posts

Exploring Genetic Diversity and Virulence in Cupriavidus

Exploring Genetic Diversity and Virulence in Cupriavidus

October 2, 2025

Tiny Cellular Messengers in Obesity Speed Up Alzheimer’s-Related Brain Plaque Formation

October 2, 2025

Improving Ethiopian Livestock: Quality Challenges and Solutions

October 2, 2025

Can Elephants Sense When We’re Watching Them?

October 2, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    91 shares
    Share 36 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    77 shares
    Share 31 Tweet 19
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Prognostic Factors in Advanced Cervical Cancer

Sure! Here’s a rewritten version of the headline tailored for a science magazine post about Bronchiectasis and NTM Research Registry data presented at the European Respiratory Society Congress: “New Insights into Bronchiectasis and NTM Infections Unveiled from Research Registry Data at European Respiratory Society Congress” If you want, I can also help rewrite the two abstracts themselves or create a more detailed magazine-style summary based on them. Just let me know!

Platelet Activation Drives Inflammation in Myasthenia Gravis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.